Search results

Non-titrated quality control human citrated plasma for coagulation assays. Dilution plasma for the assay of lupus anticoagulant (LA) with usual laboratory methods.

Quality control plasma for the corresponding clotting or chromogenic assays, and for non mutated FV (not resistant to APC).

Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.

Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.

Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.

Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.

Assay proposed for the measurement of prothrombin (Factor II) in research applications.

Liquid "ready for use", containing synthetic phospholipid blend. This kit is intended for use in the European Pharmacopoeia (EP) method for the detection of activated coagulation factors in therapeutic products. Also, the NAPTT reagent alone can be used in the NAPTT test for detecting contact activation and hypercoagulability (For Research Use Only).

Reagent with low phospholipid concentration for lupus anticoagulants (LA) determination. The presence of LA prolongs clotting time.

Reagent with low phospholipid concentration for confirming the presence of lupus anticoagulants (LA). The presence of LA does not or only insignificantly prolong clotting time.